JP2019528793A5 - - Google Patents

Download PDF

Info

Publication number
JP2019528793A5
JP2019528793A5 JP2019538714A JP2019538714A JP2019528793A5 JP 2019528793 A5 JP2019528793 A5 JP 2019528793A5 JP 2019538714 A JP2019538714 A JP 2019538714A JP 2019538714 A JP2019538714 A JP 2019538714A JP 2019528793 A5 JP2019528793 A5 JP 2019528793A5
Authority
JP
Japan
Prior art keywords
vector
polynucleotide
adeno
promoter
associated virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019538714A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019528793A (ja
JP7059285B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/074081 external-priority patent/WO2018060097A1/en
Publication of JP2019528793A publication Critical patent/JP2019528793A/ja
Publication of JP2019528793A5 publication Critical patent/JP2019528793A5/ja
Application granted granted Critical
Publication of JP7059285B2 publication Critical patent/JP7059285B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019538714A 2016-09-30 2017-09-22 ムコ多糖症の治療のためのアデノ随伴ウイルスベクター Expired - Fee Related JP7059285B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16382450 2016-09-30
EP16382450.1 2016-09-30
PCT/EP2017/074081 WO2018060097A1 (en) 2016-09-30 2017-09-22 Adenoassociated virus vectors for the treatment of mucopolysaccharidoses

Publications (3)

Publication Number Publication Date
JP2019528793A JP2019528793A (ja) 2019-10-17
JP2019528793A5 true JP2019528793A5 (https=) 2020-11-12
JP7059285B2 JP7059285B2 (ja) 2022-04-25

Family

ID=57123944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019538714A Expired - Fee Related JP7059285B2 (ja) 2016-09-30 2017-09-22 ムコ多糖症の治療のためのアデノ随伴ウイルスベクター

Country Status (10)

Country Link
US (1) US11338046B2 (https=)
EP (1) EP3519569B1 (https=)
JP (1) JP7059285B2 (https=)
CN (1) CN109863243B (https=)
AR (1) AR109752A1 (https=)
AU (1) AU2017333336B2 (https=)
ES (1) ES2859661T3 (https=)
PT (1) PT3519569T (https=)
TW (1) TW201814044A (https=)
WO (1) WO2018060097A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2605798A1 (en) 2010-07-12 2013-06-26 Universidad Autònoma de Barcelona Gene therapy composition for use in diabetes treatment
EP2692868A1 (en) 2012-08-02 2014-02-05 Universitat Autònoma De Barcelona Adeno-associated viral (AAV) vectors useful for transducing adipose tissue
CN115120746A (zh) 2013-05-15 2022-09-30 明尼苏达大学董事会 腺相关病毒介导的基因向中枢神经系统转移
EP3194430A1 (en) 2014-09-16 2017-07-26 Universitat Autònoma De Barcelona Adeno-associated viral vectors for the gene therapy of metabolic diseases
US11085055B2 (en) 2014-12-05 2021-08-10 Universitat Autonoma De Barcelona Viral vectors for the treatment of diabetes
US11033638B2 (en) 2015-01-07 2021-06-15 Universität Autonoma De Barcelona Single-vector gene construct comprising insulin and glucokinase genes
IL270882B2 (en) 2017-05-24 2024-02-01 Univ Barcelona Autonoma Viral expression vectors containing the coding sequence for FIBROBLAST GROWTH FACTOR 21 (FGF21
MX2020011386A (es) 2018-04-27 2021-01-29 Spacecraft Seven Llc Terapia genica para la degeneracion del snc.
MX2020012911A (es) * 2018-05-30 2021-02-26 Esteve Pharmaceuticals Sa Vectores de virus adenoasociados para el tratamiento de mucopolisacaridosis tipo iv a.
KR102918544B1 (ko) * 2018-07-12 2026-01-27 로켓 파마슈티컬스, 리미티드 다논병을 치료하기 위한 유전자 요법 벡터
ES2948620T3 (es) 2019-07-10 2023-09-14 Masonic Medical Res Laboratory Vgll4 con elemento regulador CIS de UCP-1 y método de uso del mismo
CN111718947B (zh) * 2020-06-18 2022-08-23 舒泰神(北京)生物制药股份有限公司 用于治疗ⅲa或ⅲb型粘多糖贮积症的腺相关病毒载体及用途
KR20230043869A (ko) 2020-08-07 2023-03-31 스페이스크래프트 세븐, 엘엘씨 Aav 벡터를 사용한 플라코필린-2(pkp2) 유전자 요법
CN114480454B (zh) * 2020-10-27 2024-03-29 华东理工大学 用于治疗粘多糖贮积症ⅱ型的腺相关病毒载体、药物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232670B2 (en) * 2001-09-28 2007-06-19 St. Jude Children's Research Hospital Targeting proteins to cells expressing mannose receptors via expression in insect cells
CA2515708A1 (en) * 2003-02-11 2004-08-26 Transkaryotic Therapies, Inc. Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies
EP2394667A1 (en) 2010-06-10 2011-12-14 Laboratorios Del Dr. Esteve, S.A. Vectors and sequences for the treatment of diseases
JP6188728B2 (ja) 2012-02-07 2017-08-30 グローバル・バイオ・セラピューティクス・インコーポレイテッドGlobal Bio Therapeutics,Inc. 核酸送達の区画化方法ならびにその組成物および使用
CN105916990B (zh) * 2013-08-02 2020-02-04 巴塞罗那自治大学 用于转导脂肪组织的腺相关病毒载体
CN105745326A (zh) * 2013-10-24 2016-07-06 优尼科Ip有限公司 用于基因治疗神经疾病的aav-5假型载体
GB201322798D0 (en) * 2013-12-20 2014-02-05 Oxford Biomedica Ltd Production system
CA2947468C (en) 2014-05-14 2022-10-25 Laboratorios Del Dr. Esteve S.A. Adenoassociated virus vectors for the treatment of lysosomal storage disorders
CN107530447A (zh) * 2015-02-10 2018-01-02 建新公司 病毒颗粒至纹状体和皮质的增强递送
US9981021B1 (en) * 2015-04-09 2018-05-29 Kinetiq, Inc. Subcutaneous therapeutic enzyme formulations, uses, and methods for generating thereof

Similar Documents

Publication Publication Date Title
JP2019528793A5 (https=)
JP2018517414A5 (https=)
RU2016149206A (ru) Аденоассоциированные вирусные векторы для лечения лизосомных болезней накопления
RU2017142006A (ru) Векторы на основе аденоассоциированных вирусов для лечения мукополисахаридозов
Komoto et al. Reverse genetics system demonstrates that rotavirus nonstructural protein NSP6 is not essential for viral replication in cell culture
JP2020022459A5 (https=)
FI3313991T3 (fi) Muunnettu tekijä IX sekä koostumukset, menetelmät ja käytöt geeninsiirtoa varten soluihin, elimiin ja kudoksiin
JP2014012022A5 (https=)
JP2014239686A5 (https=)
HRP20180146T1 (hr) Vektori i sljedovi namijenjeni liječenju bolesti
JP2018520997A5 (https=)
BR112019016769A2 (pt) Métodos e composições para transferência genética através da vasculatura
JP2015523379A5 (https=)
JP2019519219A5 (https=)
JP2020522269A5 (https=)
FI3684423T3 (fi) Adenoassesioidun viruksen kapsidivariantteja ja niiden käyttömenetelmiä
JP2020500541A5 (https=)
JP2022514955A5 (https=)
JP2016520290A5 (https=)
JP2016538885A5 (https=)
JP2013509168A5 (https=)
JP2018534950A5 (https=)
JP2016512683A5 (https=)
JP2019522461A5 (https=)
JP2016028035A5 (https=)